Skip to content

EBIT at other companies

Astrana Health logo
Astrana HealthASTH
$28.53M+38.6%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$7.42M+42.2%
Alignment Healthcare logo
Alignment HealthcareALHC
$15.5M+387%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$27.33M+2,246%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$141.77M+41.3%
CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Calculated from Agilon Health’s reported figures.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's EBIT?
Agilon Health (AGL) reported EBIT of $4M in Q1 2026.
How has Agilon Health's EBIT changed year-over-year?
Agilon Health's EBIT increased by 118.1% year-over-year, from -$22.11M to $4M.
What is the long-term trend for Agilon Health's EBIT?
Over 4 years (2021 to 2025), Agilon Health's EBIT has grown at a 5.6% compound annual growth rate (CAGR), from -$372.24M to -$463.24M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.